by The Scripps Research Institute The U.S. Food and Drug Administration has approved ozanimod, an immune-modulating therapy invented at Scripps Research, for the treatment of adults with relapsing forms of multiple sclerosis. The drug is also in advanced clinical development for adults and children with moderate-to-severe ulcerative colitis and Crohn’s disease. In patient studies supporting...
AMERICAN THORACIC SOCIETY In a new study, researchers found that half of the patients they treated for mild COVID-19 infection still had coronavirus for up to eight days after symptoms disappeared. The research letter was published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine. In “Time Kinetics of Viral...
Existing vaporized hydrogen peroxide methods can decontaminate N95 face masks for reuse, confirm research and clinical teams. Health care providers are facing a critical shortage of N95 face masks that block the coronavirus. The process uses specialized equipment to aerosolize hydrogen peroxide, which permeates the layers of the mask to kill germs, including viruses, without...
by University of Texas Health Science Center at Houston COVID-19 can have fatal consequences for people with underlying cardiovascular disease and cause cardiac injury even in patients without underlying heart conditions, according to a review published today in JAMA Cardiology by experts at The University of Texas Health Science Center at Houston (UTHealth). Experts have...
Researchers from the University of California, Irvine have conducted a statistical analysis that predicts more than 70,000 heart attacks, strokes and other adverse cardiovascular events could be prevented each year in the U.S. through the use of a highly purified fish oil therapy. Led by Nathan D. Wong, PhD, professor and director of the Heart...
by University of Miami Leonard M. Miller School of Medicine As the COVID-19 pandemic unfolds, inaccurate medical information has flooded social media and other channels. One potentially lethal example is that patients who take renin-angiotensin system (RAS) blockers, particularly angiotensin II type 1 receptor blockers (ARBs), may be more susceptible to the virus. However, in...
A US-based lab has unveiled a portable test that can tell if someone has COVID-19 in as little as five minutes, it said in a statement Friday. Abbott Laboratories said the US Food and Drug Administration (FDA) had given it emergency authorization to begin making the test available to healthcare providers as early as next...
by The Francis Crick Institute A new method to accurately record brain activity at scale has been developed by researchers at the Crick, Stanford University and UCL. The technique could lead to new medical devices to help amputees, people with paralysis or people with neurological conditions such as motor neurone disease. The research in mice,...
A mechanism that enables cancer cells to scavenge dead cell debris for nourishment may lead to new ways to overcome drug resistance, a new study shows. Drug resistance remains a major challenge in the fight against cancer. “Cancer cells require a tremendous amount of nutrients,” says Aimee Edinger, professor of developmental and cell biology at...
By Rich Haridy The link between diseases such as Alzheimer’s and sleep loss has been frequently cited by researchers, and a new study led by scientists from the University of Pennsylvania has discovered a signaling pathway that both regulates sleep and controls the protein aggregations commonly associated with neurodegeneration. It’s hoped the discovery will lead...
